HIV News and Research

RSS

National #KnowBetterDoBetter movement comes to Houston to end AIDS epidemic

The national #KnowBetterDoBetter movement led by the Black AIDS Institute (BAI) is coming to Houston and the message is loud and clear- we can end the AIDS epidemic if we fully engage non-medical workers on the frontline of the battle with greater knowledge and skills.

6 Feb 2015

National #KnowBetterDoBetter movement comes to Chicagoland to end AIDS epidemic

The national #KnowBetterDoBetter movement led by the Black AIDS Institute (BAI) is coming to Chicagoland and the message is loud and clear- we can end the AIDS epidemic if we fully engage non-medical workers on the frontline of the battle with the greater knowledge and skills.

6 Feb 2015

BAI-led #KnowBetterDoBetter movement comes to Broward County to eliminate HIV/AIDS

The national #KnowBetterDoBetter movement led by the Black AIDS Institute (BAI) is coming to Broward County and the message is loud and clear- we can end the AIDS epidemic if we fully engage non-medical workers on the frontline of the battle with greater knowledge and skills.

6 Feb 2015

National #KnowBetterDoBetter movement comes to Bay Area to eliminate HIV and AIDS

The national #KnowBetterDoBetter movement led by the Black AIDS Institute (BAI) is coming to the Bay Area and the message is loud and clear- we can end the AIDS epidemic if we fully engage non-medical workers on the frontline of the battle with greater knowledge and skills.

6 Feb 2015

National #KnowBetterDoBetter movement comes to Charlotte, NC to eradicate HIV/AIDS

The national #KnowBetterDoBetter movement led by the Black AIDS Institute (BAI) is coming to Charlotte, NC and the message is loud and clear- we can end the AIDS epidemic if we fully engage non-medical workers on the frontline of the battle with greater knowledge and skills.

6 Feb 2015

Researchers develop smartphone accessory for rapid diagnosis of infectious diseases at point of care

A team of researchers, led by Samuel K. Sia, associate professor of biomedical engineering at Columbia Engineering, has developed a low-cost smartphone accessory that can perform a point-of-care test that simultaneously detects three infectious disease markers from a finger prick of blood in just 15 minutes.

5 Feb 2015

Three Keck Medicine scientists of USC receive $4.3 million from CIRM for stem cell research

Three scientists from Keck Medicine of the University of Southern California have won grants exceeding $4.3 million from the California Institute for Regenerative Medicine for research that includes creating a temporary liver for transplant patients, finding novel ways to treat immune disorders and blood diseases and developing a new animal model for exploring diseases like heart failure, diabetes and neurodegenerative diseases.

5 Feb 2015

Howard K. Koh receives CADCA's 2015 National Leadership Award

In recognition of his significant contributions to public health and tobacco prevention, and his long-standing support of community-based drug prevention, Community Anti-Drug Coalitions of America (CADCA) will present Howard K. Koh M.D., M.P.H. with its 2015 National Leadership Award.

5 Feb 2015

Diplomat to dispense FDA-approved IBRANCE (palbociclib) to treat metastatic breast cancer

Diplomat Pharmacy, Inc., the nation's largest independent specialty pharmacy, announced today it will dispense Pfizer's new breakthrough medication, IBRANCE (palbociclib), starting tomorrow, Feb. 5.

4 Feb 2015

Epidemiologist urges people to get vaccinated against measles

Americans may be victims of their own success when it comes to the eradication of infectious diseases and take their disease-free lives for granted, says Jorge Parada, MD, hospital epidemiologist and medical director of the Infection Prevention and Control program at Loyola University Health System.

4 Feb 2015

FDA accepts Sangamo BioSciences' IND for SB-BCLmR-HSPC genome editing approach

Sangamo BioSciences, Inc. announced today that an Investigational New Drug (IND) application for the company's SB-BCLmR-HSPC genome editing approach, which is designed to provide a one-time lasting therapy for beta-thalassemia, has been accepted by the U.S. Food and Drug Administration and is now active.

4 Feb 2015

Researchers suggest novel concept for developing vaccines against HIV and cancer

A experimental trial has shown successful by inducing serum in mice and has been highly neutralizing towards those ailments.

4 Feb 2015

HIV science and treatment knowledge can end AIDS epidemic in the US

The scientific evidence is clear. As a result of extraordinary advances in biomedical research, we now have the tools we need to end the HIV epidemic in the United States. Or do we?

4 Feb 2015

Winners of Verizon Powerful Answers Award bring solutions to redefine the world

Four great ideas were named first place winners of the Verizon Powerful Answers Award, a year-long global challenge to discover and help bring to market technology-based solutions with the potential to change our world.

4 Feb 2015

BioMed Realty Trust expands footprint in Seattle's core innovation district of South Lake Union

BioMed Realty Trust, Inc. today announced that it is under contract to acquire the 307 Westlake Avenue North building in the heart of the burgeoning South Lake Union life science market of Seattle, Washington for approximately $90 million.

4 Feb 2015

MGH, MIT researchers reveal how the brain controls different sleep states

Researchers at Massachusetts General Hospital and Massachusetts Institute of Technology have added another piece to the complex puzzle of how the brain controls one of the most essential functions - sleep.

4 Feb 2015

One in four nonsmokers still exposed to secondhand smoke, shows CDC report

Although secondhand smoke (SHS) exposure in the United States dropped by half between 1999 to 2000 and 2011 to 2012, one in four nonsmokers -- 58 million people -- are still exposed to SHS, according to a new Vital Signs report from the Centers for Disease Control and Prevention.

4 Feb 2015

Research opens door to development of new therapies to block HIV-associated neurocognitive disorders

While antiretroviral therapies have significantly improved and extended the lives of many HIV patients, another insidious and little discussed threat looms for aging sufferers - HIV-associated neurocognitive disorders (HAND). The disorders, which strike more often in HIV patients over age 50, can result in cognitive impairment, mild to severe, making everyday tasks a challenge.

3 Feb 2015

Theravance Biopharma, Mylan partner to develop and commercialize TD-4208 for COPD treatment

Theravance Biopharma, Inc. and Mylan Inc. today announced that the two companies will partner on the development and, subject to FDA approval, commercialization of TD-4208, a novel investigational once-daily nebulized long-acting muscarinic antagonist (LAMA) for chronic obstructive pulmonary disease (COPD) and other respiratory diseases.

2 Feb 2015

Mylan signs definitive agreement to acquire Famy Care's female health care businesses

Mylan Inc. today announced that it has, through its Indian subsidiary Mylan Laboratories Limited, signed a definitive agreement to acquire certain female health care businesses from Famy Care Limited, a specialty women's health care company with global leadership in generic oral contraceptive products (OCPs) for $750 million in cash plus additional contingent payments of up to $50 million.

2 Feb 2015

HIV News and Research

National #KnowBetterDoBetter movement comes to Houston to end AIDS epidemic

National #KnowBetterDoBetter movement comes to Chicagoland to end AIDS epidemic

BAI-led #KnowBetterDoBetter movement comes to Broward County to eliminate HIV/AIDS

National #KnowBetterDoBetter movement comes to Bay Area to eliminate HIV and AIDS

National #KnowBetterDoBetter movement comes to Charlotte, NC to eradicate HIV/AIDS

Researchers develop smartphone accessory for rapid diagnosis of infectious diseases at point of care

Three Keck Medicine scientists of USC receive $4.3 million from CIRM for stem cell research

Howard K. Koh receives CADCA's 2015 National Leadership Award

Diplomat to dispense FDA-approved IBRANCE (palbociclib) to treat metastatic breast cancer

Epidemiologist urges people to get vaccinated against measles

FDA accepts Sangamo BioSciences' IND for SB-BCLmR-HSPC genome editing approach

Researchers suggest novel concept for developing vaccines against HIV and cancer

HIV science and treatment knowledge can end AIDS epidemic in the US

Winners of Verizon Powerful Answers Award bring solutions to redefine the world

BioMed Realty Trust expands footprint in Seattle's core innovation district of South Lake Union

MGH, MIT researchers reveal how the brain controls different sleep states

One in four nonsmokers still exposed to secondhand smoke, shows CDC report

Research opens door to development of new therapies to block HIV-associated neurocognitive disorders

Theravance Biopharma, Mylan partner to develop and commercialize TD-4208 for COPD treatment

Mylan signs definitive agreement to acquire Famy Care's female health care businesses

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News